Market Cap : 2.65 B | Enterprise Value : 2.21 B | PE Ratio : 26.56 | PB Ratio : 5.05 |
---|
NAS:CORT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:CORT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Corcept Therapeutics's Tax Expense for the three months ended in Dec. 2020 was $4.8 Mil. Corcept Therapeutics's Pre-Tax Income for the three months ended in Dec. 2020 was $30.8 Mil. Therefore, Corcept Therapeutics's Tax Rate % for the quarter that ended in Dec. 2020 was 15.62%.
* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.
Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.
Corcept Therapeutics's Tax Rate % for the fiscal year that ended in Dec. 2020 is calculated as
Tax Rate % | = | Tax Expense (A: Dec. 2020 ) | / | Pre-Tax Income (A: Dec. 2020 ) |
= | 25.591 | / | 131.602 | |
= | 19.45 % |
Corcept Therapeutics's Tax Rate % for the quarter that ended in Dec. 2020 is calculated as
Tax Rate % | = | Tax Expense (Q: Dec. 2020 ) | / | Pre-Tax Income (Q: Dec. 2020 ) |
= | 4.813 | / | 30.807 | |
= | 15.62 % |
* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.
No Headline